Most interestingly, the liposomal‐activated NK cells can precisely identify and kill the dying tumor cells induced by chemotherapeutic agents, thus leading to an immune‐responsive TME via STING–IFN pathway that further enhanced the immunotherapy effectiveness.406. The gene discussed is STING1; the disease is neoplasm.